Pfizer Inc has made an agreed cash offer to buy Medivation Inc for about $14 billion or an eye-popping 5.8 times the average revenue that Medivation has forecast for 2016. Long gone are the days when one times revenue was considered a reasonable purchase price for an industrial company.
